Company / Cash & Equivalents
U.S. Physical Therapy, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$35.6M
FY2025
5-year range
$28.6M / $152.8M
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#137 of 148
Health Care
What the data says
Among 148 Health Care companies, U.S. Physical Therapy, Inc. is in the bottom 7% for cash & equivalents. Cash & Equivalents has fluctuated over the past 10 years, ranging from $14M in FY2016 to $153M in FY2023.
Based on SEC 10-K filings.
$36M in FY2025 with a 5-year CAGR of +1.6%.
Declined from $153M to $36M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 148This company $35.6M Sector average $1.2B
▼
-97.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 14.0% year-over-year.
- Ranks #137 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2023.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.6M | -14.0% |
| FY2024 | $41.4M | -72.9% |
| FY2023 | $152.8M | +383.7% |
| FY2022 | $31.6M | +10.6% |
| FY2021 | $28.6M | -13.2% |
| FY2020 | $32.9M | +39.8% |
| FY2019 | $23.5M | +0.8% |
| FY2018 | $23.4M | +48.1% |
| FY2017 | $15.8M | +10.6% |
| FY2016 | $14.3M | -9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026